279 related articles for article (PubMed ID: 15319354)
1. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide.
Alemzadeh R; Tushaus KM
Endocrinology; 2004 Dec; 145(12):5476-84. PubMed ID: 15319354
[TBL] [Abstract][Full Text] [Related]
2. Diazoxide attenuates insulin secretion and hepatic lipogenesis in zucker diabetic fatty rats.
Alemzadeh R; Tushaus K
Med Sci Monit; 2005 Dec; 11(12):BR439-48. PubMed ID: 16319780
[TBL] [Abstract][Full Text] [Related]
3. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
Alemzadeh R; Karlstad MD; Tushaus K; Buchholz M
Metabolism; 2008 Nov; 57(11):1597-607. PubMed ID: 18940400
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.
Alemzadeh R; Fledelius C; Bodvarsdottir T; Sturis J
Metabolism; 2004 Apr; 53(4):441-7. PubMed ID: 15045689
[TBL] [Abstract][Full Text] [Related]
5. Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats.
Standridge M; Alemzadeh R; Zemel M; Koontz J; Moustaid-Moussa N
FASEB J; 2000 Mar; 14(3):455-60. PubMed ID: 10698960
[TBL] [Abstract][Full Text] [Related]
6. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
7. Effect of diazoxide on brain capillary insulin receptor binding and food intake in hyperphagic obese Zucker rats.
Alemzadeh R; Holshouser S
Endocrinology; 1999 Jul; 140(7):3197-202. PubMed ID: 10385415
[TBL] [Abstract][Full Text] [Related]
8. Chronic suppression of insulin by diazoxide alters the activities of key enzymes regulating hepatic gluconeogenesis in Zucker rats.
Alemzadeh R; Holshouser S; Massey P; Koontz J
Eur J Endocrinol; 2002 Jun; 146(6):871-9. PubMed ID: 12039709
[TBL] [Abstract][Full Text] [Related]
9. Low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of Zucker diabetic fatty rats.
MacDonald MJ; Tang J; Polonsky KS
Diabetes; 1996 Nov; 45(11):1626-30. PubMed ID: 8866570
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes.
Shimabukuro M; Zhou YT; Levi M; Unger RH
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2498-502. PubMed ID: 9482914
[TBL] [Abstract][Full Text] [Related]
11. Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
Zhou YP; Cockburn BN; Pugh W; Polonsky KS
Metabolism; 1999 Jul; 48(7):857-64. PubMed ID: 10421226
[TBL] [Abstract][Full Text] [Related]
12. Modification of insulin resistance by diazoxide in obese Zucker rats.
Alemzadeh R; Slonim AE; Zdanowicz MM; Maturo J
Endocrinology; 1993 Aug; 133(2):705-12. PubMed ID: 8344209
[TBL] [Abstract][Full Text] [Related]
13. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
[TBL] [Abstract][Full Text] [Related]
14. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
Gowda N; Dandu A; Singh J; Biswas S; Raghav V; Lakshmi MN; Shilpa PC; Sunil V; Reddy A; Sadasivuni M; Aparna K; Verma MK; Moolemath Y; Anup MO; Venkataranganna MV; Somesh BP; Jagannath MR
BMC Pharmacol Toxicol; 2013 May; 14():28. PubMed ID: 23692921
[TBL] [Abstract][Full Text] [Related]
15. Diazoxide enhances adipose tissue protein kinase B activation and glucose transporter-4 expression in obese Zucker rats.
Alemzadeh R; Zhang J; Tushaus K; Koontz J
Med Sci Monit; 2004 Mar; 10(3):BR53-60. PubMed ID: 14976464
[TBL] [Abstract][Full Text] [Related]
16. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
Delghingaro-Augusto V; Décary S; Peyot ML; Latour MG; Lamontagne J; Paradis-Isler N; Lacharité-Lemieux M; Akakpo H; Birot O; Nolan CJ; Prentki M; Bergeron R
Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E254-64. PubMed ID: 22045312
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.
Cai XJ; Lister CA; Buckingham RE; Pickavance L; Wilding J; Arch JR; Wilson S; Williams G
Brain Res Mol Brain Res; 2000 Apr; 77(1):131-7. PubMed ID: 10814839
[TBL] [Abstract][Full Text] [Related]
18. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
[TBL] [Abstract][Full Text] [Related]
19. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats.
Harmon JS; Gleason CE; Tanaka Y; Poitout V; Robertson RP
Diabetes; 2001 Nov; 50(11):2481-6. PubMed ID: 11679425
[TBL] [Abstract][Full Text] [Related]
20. Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes.
Zhou YT; Shimabukuro M; Lee Y; Koyama K; Higa M; Ferguson T; Unger RH
Diabetes; 1998 Dec; 47(12):1904-8. PubMed ID: 9836522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
